Items where authors include "Müller, R.-U."

Article

Bais, T., Meijer, E. orcid.org/0000-0001-7875-1793, Kramers, B.J. et al. (15 more authors) (2024) HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial. Trials, 25 (1). 120. ISSN 1745-6215

Debès, C., Papadakis, A., Grönke, S. orcid.org/0000-0002-1539-5346 et al. (23 more authors) (2023) Ageing-associated changes in transcriptional elongation influence longevity. Nature, 616 (7958). pp. 814-821. ISSN 0028-0836

Müller, R.-U., Lianne Messchendorp, A., Birn, H. et al. (20 more authors) (2022) An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Kidneys, 11 (1). pp. 37-39. ISSN 2307-1257

Müller, R.-U., Messchendorp, A.L., Birn, H. et al. (20 more authors) (2022) An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Nephrology Dialysis Transplantation, 37 (5). pp. 825-839. ISSN 0931-0509